Pharmacodynamic and predictive biomarker results from the phase I dose escalation study of NGM707, an ILT2/ILT4 dual antagonist antibody, in patients with advanced solid tumorsCANCER RESEARCHIF16.62024-03-220PRE
A target discovery pipeline identified ILT3 as a target for immunotherapy of multiple myelomaCELL REPORTS MEDICINEIF10.62023-07-0114OAAI
Reduced Wheel Running via a High-Fat Diet Is Reversed by a Chow Diet with No Added Benefit from Fecal Microbial TransplantsMEDICINE & SCIENCE IN SPORTS & EXERCISEIF3.92022-09-013PRE
A High Fat/High Sugar Diet Alters the Gastrointestinal Metabolome in a Sex Dependent MannerMETABOLITESIF3.72020-10-206OAAI